Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas
- 1 June 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (9) , 1418-1422
- https://doi.org/10.1016/j.ejca.2004.01.036
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Chemotherapy for Advanced Pancreatic CancerPublished by Springer Nature ,2012
- Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985?International Journal of Radiation Oncology*Biology*Physics, 2003
- Chemotherapy for advanced pancreatic cancerInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Clinical research in pancreatic cancer: The Radiation Therapy Oncology Group trialsInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Oral squamous cell carcinoma: electron microscopic and immunohistochemical characteristicsMedical Molecular Morphology, 2002
- Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin.International Journal of Oncology, 2000
- Transferrin Receptor Induction by HypoxiaJournal of Biological Chemistry, 1999
- Recombinant Immunocytokines Targeting the Mouse Transferrin Receptor: Construction and Biological ActivitiesBioconjugate Chemistry, 1998
- Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fractionVirchows Archiv, 1990
- Transferrin receptors in human cancerous tissues.The Tohoku Journal of Experimental Medicine, 1987